26th Apr 2017 14:15
For immediate release | 26 April 2017 |
Quantum Pharma Plc
('Quantum' or the 'Group')
Administration of NuPharm
Quantum Pharma Plc (AIM: QP.), the service-led niche pharmaceutical developer, manufacturer and supplier, announces that following the cessation of trading at NuPharm Laboratories Limited ('NuPharm') in January, NuPharm was placed into administration earlier today. In accordance with paragraph (g) of Schedule 2 of the AIM Rules for Companies, Quantum confirms that Chris Rigg, CEO, was also a director of NuPharm when it was placed into administration.
- Ends -
For further information: |
| |||||
Quantum Pharma Plc |
| |||||
Chris Rigg, Chief Executive Officer | Tel: +44 (0) 1207 279 404 | |||||
Gerard Murray, Chief Financial Officer | www.quantumpharmaplc.com | |||||
| ||||||
N+1 Singer |
|
| ||||
(Nominated Advisor & Broker) |
|
| ||||
Sandy Fraser / Nick Owen / James White | Tel: +44 (0) 20 7496 3000 |
| ||||
Media enquiries: |
|
| ||||
Buchanan |
|
| ||||
Henry Harrison-Topham | Tel: +44 (0) 20 7466 5000 |
| ||||
www.buchanan.uk.com |
| |||||
|
|
| ||||
Notes to Editors
Quantum Pharma is a service-led, niche pharmaceutical developer, manufacturer and supplier to the retail pharmacy, pharmaceutical wholesale, hospital, homecare and care home markets. Quantum Pharma operates through three divisions - Specials, Niche Pharmaceuticals and Medication Adherence - offering a portfolio of innovative and complementary products and services.
For further information, please visit www.quantumpharmagroup.com.
Related Shares:
Quantum Pharma